Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Zandelisib is an inhibitor of phosphatidylinositol 3-kinase (PI3K)(p110δ, IC50 of 3.5 nM), and with antineoplastic activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 148.00 | |
5 mg | In stock | $ 317.00 | |
10 mg | In stock | $ 528.00 | |
25 mg | In stock | $ 856.00 | |
50 mg | In stock | $ 1,180.00 | |
100 mg | In stock | $ 1,590.00 | |
500 mg | In stock | $ 3,180.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 395.00 |
Description | Zandelisib is an inhibitor of phosphatidylinositol 3-kinase (PI3K)(p110δ, IC50 of 3.5 nM), and with antineoplastic activity. |
Targets&IC50 | PI3Kδ:3.5 nM |
In vitro | Zandelisib inhibits PI3Ks(p110α, p110β, p110γ and p110δ with IC50s of 4, 976 nM, 605 nM, 817 nM and 3.5 nM, respectivey)[1]. |
Molecular Weight | 576.68 |
Formula | C31H38F2N8O |
CAS No. | 1401436-95-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 33.33 mg/mL (57.80 mM), when pH Adjusted to 3 with HCl. Sonication and heating to 60℃ are recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Zandelisib 1401436-95-0 PI3K/Akt/mTOR signaling PI3K PWT143 3-kinase Phosphatidylinositol inhibit ME401 Phosphoinositide 3-kinase PWT-143 PWT 143 antineoplastic ME-401 ME 401 Inhibitor p110δ inhibitor